As of August 17, 2011 we have been engaged to audit the December 31 2010 financial statements of Biopharm Asia, Inc. and Subsidiaries.
Maurice Berkower
I just received this email a few minutes ago. Isn't this a green light to buy? If the numbers weren't true, would BFAR have hired ACSB to audit their financials?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.